Jade Biosciences (JBIO) Competitors $8.28 -0.05 (-0.60%) As of 07/25/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsOwnershipSEC FilingsTrendsBuy This Stock JBIO vs. MIRA, GBIO, ENLV, SCYX, NNVC, QTTB, RANI, FBLG, NRSN, and CLSDShould you be buying Jade Biosciences stock or one of its competitors? The main competitors of Jade Biosciences include MIRA Pharmaceuticals (MIRA), Generation Bio (GBIO), Enlivex Therapeutics (ENLV), SCYNEXIS (SCYX), NanoViricides (NNVC), Q32 Bio (QTTB), Rani Therapeutics (RANI), FibroBiologics (FBLG), NeuroSense Therapeutics (NRSN), and Clearside Biomedical (CLSD). These companies are all part of the "pharmaceutical products" industry. Jade Biosciences vs. Its Competitors MIRA Pharmaceuticals Generation Bio Enlivex Therapeutics SCYNEXIS NanoViricides Q32 Bio Rani Therapeutics FibroBiologics NeuroSense Therapeutics Clearside Biomedical Jade Biosciences (NASDAQ:JBIO) and MIRA Pharmaceuticals (NASDAQ:MIRA) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends, media sentiment and earnings. Which has better earnings & valuation, JBIO or MIRA? MIRA Pharmaceuticals is trading at a lower price-to-earnings ratio than Jade Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioJade BiosciencesN/AN/A-$69.63M-$59.65-0.14MIRA PharmaceuticalsN/AN/A-$7.85M-$0.51-3.39 Does the media prefer JBIO or MIRA? In the previous week, Jade Biosciences and Jade Biosciences both had 1 articles in the media. Jade Biosciences' average media sentiment score of 1.89 beat MIRA Pharmaceuticals' score of 1.87 indicating that Jade Biosciences is being referred to more favorably in the media. Company Overall Sentiment Jade Biosciences Very Positive MIRA Pharmaceuticals Very Positive Do insiders & institutionals have more ownership in JBIO or MIRA? 35.2% of MIRA Pharmaceuticals shares are held by institutional investors. 24.9% of Jade Biosciences shares are held by insiders. Comparatively, 6.7% of MIRA Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has more volatility & risk, JBIO or MIRA? Jade Biosciences has a beta of 1.06, meaning that its share price is 6% more volatile than the S&P 500. Comparatively, MIRA Pharmaceuticals has a beta of 1.72, meaning that its share price is 72% more volatile than the S&P 500. Do analysts rate JBIO or MIRA? Jade Biosciences currently has a consensus price target of $15.00, suggesting a potential upside of 81.16%. MIRA Pharmaceuticals has a consensus price target of $14.00, suggesting a potential upside of 709.25%. Given MIRA Pharmaceuticals' stronger consensus rating and higher probable upside, analysts plainly believe MIRA Pharmaceuticals is more favorable than Jade Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jade Biosciences 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00MIRA Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Is JBIO or MIRA more profitable? Jade Biosciences' return on equity of -60.01% beat MIRA Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Jade BiosciencesN/A -60.01% -54.32% MIRA Pharmaceuticals N/A -341.08%-272.93% SummaryMIRA Pharmaceuticals beats Jade Biosciences on 7 of the 12 factors compared between the two stocks. Get Jade Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for JBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding JBIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart JBIO vs. The Competition Export to ExcelMetricJade BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$7M$3.05B$5.70B$9.50BDividend YieldN/A2.37%4.58%4.00%P/E Ratio-0.1421.3228.3920.08Price / SalesN/A285.38431.7689.31Price / CashN/A42.7636.2258.56Price / Book0.098.378.675.88Net Income-$69.63M-$55.19M$3.25B$258.89M7 Day Performance-12.57%5.86%4.25%3.71%1 Month Performance-10.49%17.29%10.51%11.72%1 Year PerformanceN/A4.39%35.68%18.01% Jade Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)JBIOJade Biosciences2.3989 of 5 stars$8.28-0.6%$15.00+81.2%N/A$7MN/A-0.1420Positive NewsMIRAMIRA Pharmaceuticals2.5944 of 5 stars$1.75+4.2%$14.00+700.0%-43.1%$28.42MN/A-3.432GBIOGeneration Bio4.0251 of 5 stars$4.27+1.4%$80.00+1,773.5%-86.5%$28.22M$24.56M-3.95150Analyst DowngradeStock SplitHigh Trading VolumeENLVEnlivex Therapeutics2.7974 of 5 stars$1.18-0.8%$10.00+747.5%-19.3%$28.15MN/A-1.7970News CoverageAnalyst ForecastGap UpSCYXSCYNEXIS0.8915 of 5 stars$0.71-0.2%N/A-65.0%$27.76M$3.75M-1.2760Positive NewsNNVCNanoViricides0.3568 of 5 stars$1.70+0.6%N/A-24.0%$27.32MN/A-2.3620QTTBQ32 Bio2.4766 of 5 stars$2.24+2.8%$12.17+443.2%-94.2%$26.59M$1.16M-0.4539News CoverageRANIRani Therapeutics2.4906 of 5 stars$0.44+4.8%$7.33+1,566.7%-81.5%$26.55M$1.03M-0.44110Positive NewsGap UpFBLGFibroBiologics3.816 of 5 stars$0.67+0.4%$13.00+1,840.0%-85.8%$26.48MN/A-3.1910Positive NewsGap UpNRSNNeuroSense Therapeutics2.7053 of 5 stars$1.93-0.1%$14.00+626.1%+150.6%$26.38MN/A-3.5710CLSDClearside Biomedical2.2879 of 5 stars$0.35+3.7%$4.20+1,095.2%-56.0%$26.34M$1.66M-0.8630High Trading Volume Related Companies and Tools Related Companies MIRA Pharmaceuticals Competitors Generation Bio Competitors Enlivex Therapeutics Competitors SCYNEXIS Competitors NanoViricides Competitors Q32 Bio Competitors Rani Therapeutics Competitors FibroBiologics Competitors NeuroSense Therapeutics Competitors Clearside Biomedical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:JBIO) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s $100 Trillion Land Rush Is OnWhat Is "The US: IPO"? You won't hear this on CNBC... but the government may soon open up hundreds of trill...Stansberry Research | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jade Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Jade Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.